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Abstract
Much progress has been made in understanding the role of structural and accessory proteins in the
pathogenesis of severe acute respiratory syndrome coronavirus (SARS-CoV) infections. The SARS
epidemic also brought new attention to the proteins translated from ORF1a and ORF1b of the input
genome RNA, also known as the replicase/transcriptase gene. Evidence for change within the
ORF1ab coding sequence during the SARS epidemic, as well as evidence from studies with other
coronaviruses, indicates that it is likely that the ORF1ab proteins play roles in virus pathogenesis
distinct from or in addition to functions directly involved in viral replication. Recent reverse genetic
studies have confirmed that proteins of ORF1ab may be involved in cellular signaling and
modification of cellular gene expression, as well as virulence by mechanisms yet to be determined.
Thus, the evolution of the ORF1ab proteins may be determined as much by issues of host range and
virulence as they are by specific requirements for intracellular replication.
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1. Introduction
The coronaviruses express the largest and most complex polyproteins of any RNA viruses. The
polyproteins are translated from the genome RNA open reading frames 1a and 1b, and are
known as replicase, replicase/transcriptase, or polymerase polyproteins, in recognition of the
predicted and demonstrated roles in viral RNA synthesis. However, the appellation of
“replicase/transcriptase”, while appropriate, is an incomplete description of all probable
ORF1ab protein functions. It has been predicted, as well as demonstrated in some cases, that
the mature proteins in the polyprotein may serve roles distinct from or in addition to roles in
viral RNA synthesis. More specifically, it is becoming clear that proteins or protein domains
encoded in ORF1ab may serve specific roles in virulence, virus-cell interactions and/or
alterations of virus-host response.
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Two events in the history of coronavirus biology have dramatically accelerated the studies and
discoveries in protein functions: the SARS epidemic and the development of reverse genetic
strategies for the study of coronavirus replication. The rapid identification and sequencing of
SARS-CoV isolates led to bioinformatics analyses highlighting both conserved and divergent
regions of the replicase genes, particularly in relationship with known group 2 coronaviruses
such as mouse hepatitis virus (MHV). In addition, the detailed analysis of animal and human
isolates of SARS-CoV during the course of the epidemic revealed evidence of adaptive
mutations in the replicase to an extent that matched or exceeded that in the structural proteins.
Concurrently, the rapid establishment of a reverse genetic system for SARS-CoV, as well as
the development of reverse genetic systems for other group 2 coronaviruses (Yount et al.,
2003, 2002), allowed direct studies of conserved and divergent domains of the replicase in
replication. Subsequently, it has become clear that the replicase gene proteins will likely
demonstrate multiple functions, many of them novel, in viral pathogenesis. This review will
(1) summarize the organization, expression, processing, and putative replication functions of
the nonstructural proteins (nsps 1-16) of SARS-CoV; (2) describe studies of ORF1b nsps
demonstrating interactions with host cells or host immune response; (3) describe studies of
SARS-CoV nsps that support functions for the proteins in pathogenesis and adaptation.
1.1. Coronavirus life cycle
Attachment of the virion to the cell surface via a receptor constitutes the first step in the
coronavirus life cycle and is perhaps the most important tropism determinant, since coronavirus
genomes can replicate in many different cell types when transfected. Receptors vary widely
across coronaviruses: for SARS-CoV, human angiotensin converting enzyme 2 (hACE2) can
serve as a receptor (Li et al., 2003). Following attachment, the genome enters the cell via a
cathepsin L-dependent mechanism (Huang et al., 2006; Simmons et al., 2005). Once inside the
cell cytoplasm, the genome serves as an mRNA for the first open reading frame (ORF1), from
which the viral replication proteins are translated and processed. These proteins induce and
assemble on double-membrane vesicles and become the sites for viral RNA synthesis, and thus
comprise the replication complexes. These replication complexes are likely responsible for all
viral RNA synthetic activities in the viral life cycle.
Viral RNA synthesis involves two stages: in one stage, input genome RNA is replicated through
transcription of a minus-strand template. This is referred to as genome replication. In the other
stage, subgenomic mRNAs are transcribed and subsequently used for translation of structural
and accessory proteins from downstream ORFs (ORFs 2-9 for SARS-CoV). This stage is
referred to as subgenomic RNA transcription and, as it leads to translation of structural proteins,
is essential for virion formation and the completion of a productive viral replication cycle
(Sawicki and Sawicki, 2005; Sawicki et al., 2007).
All coronaviruses possess four well-characterized structural proteins: S (spike), E (envelope),
M (membrane protein), and N (nucleocapsid). These proteins are translated from subgenomic
RNAs 2, 4, 5, and 9a, respectively, in SARS-CoV. MHV studies have shown that S, E, and M
undergo modification in the Golgi prior to virus assembly (Bost et al., 2000, 2001; Klumperman
et al., 1994; Krijnse-Locker et al., 1994). The viral N protein has been shown in MHV to
colocalize with viral replicase proteins and at sites of virus assembly at late times post-infection
(Bost et al., 2000; Denison et al., 1999; Sims et al., 2000; van der Meer et al., 1999). Viral
assembly is precipitated by E and M, which induce a curvature of the budding membrane
(Raamsman et al., 2000). Interactions between M, N, and viral RNA lead to S recruitment and
RNA packaging into these structures, which form the budding virion (Narayanan et al.,
2000; Opstelten et al., 1993, 1995). The viral E protein then aids in the final pinching off of
the virion (Fischer et al., 1998). Coronavirus virions are shuttled to the cell surface in large
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exocytic vesicles, and the virions are released from the cell in a process that does not require
cell lysis.
1.2. Coronavirus genome organization and ORF1ab expression and processing
The coronavirus input genome RNA is positive-stranded and functions as an mRNA, from
which gene 1 is translated by host-cell ribosomes from two overlapping open reading frames,
ORF1a and 1b (Fig. 1). Translation of ORF1a results in a theoretical polyprotein of ~500 kDa,
while translation of ORF1ab results an ~800 kDa polyprotein (Baranov et al., 2005;Dos Ramos
et al., 2004). The ORF 1a and 1ab polyproteins are not detected during infection, since they
are most likely processed co- and post-translationally into intermediate and mature proteins by
proteinase activities in the nascent polyproteins (Harcourt et al., 2004). The number of
proteinases varies by species. All coronaviruses encode a cysteine proteinase in nsp 5 that is
referred to as the 3C-like proteinase (3CLpro), or more recently as Mpro (Anand et al.,
2003;Tan et al., 2005). The nsp 5 proteinase is responsible for processing the C-terminus of
nsp 4 through nsp 16 for all coronaviruses (Anand et al., 2003;Bost et al., 2000;Denison et al.,
1998,1999;Lu et al., 1998;Tan et al., 2005). In contrast, nsps 1-3 are cleaved by either one or
two papain-like proteinase activities (PLP) within nsp 3 (Anand et al., 2003;Bonilla et al.,
1995,1997;Dong and Baker, 1994;Harcourt et al., 2004;Kanjanahaluethai and Baker,
2001;Snijder et al., 2003;Tan et al., 2005;Teng et al., 1999;Ziebuhr et al., 2000). Group 1
(HCoV-229E) and group 2a (MHV) coronaviruses each encode PLP1 and PLP2, while group
2b (SARS-CoV) and group 3 (Avian infectious bronchitis virus—IBV) coronaviruses each
encode only one PLP in the position of PLP2. IBV possesses an inactive remnant of PLP1,
while SARS-CoV PLP1 appears to have been completely lost (Snijder et al., 2003)(Fig. 2).
Regardless of the number of PLPs present, nsps 1-3 are processed by papain-like proteinase
(s) for all coronaviruses. These distinct processing networks may serve to regulate the liberation
of intermediate and mature protein species that perform conserved functions across coronavirus
groups.
1.3. Evolution and adaptation
Prior to the SARS epidemic, studies of coronavirus evolution were limited to established
laboratory virus strains, and focused exposure to chemical mutagens and subsequent analysis
of adapted strains. The most elegant work came from studies of gradual adaptation of MHV
to Syrian baby hamster kidney (BHK) cells. The resulting passaged virus grew efficiently in
murine, hamster, human, and primate cells, clearly demonstrating the ability of coronaviruses
to cross species barriers (Baric et al., 1997). This report was remarkably prescient, coming less
than 10 years before the natural experiment of SARS-CoV transmission from animals into
humans. The SARS epidemic created a unique opportunity to study the changes in an animal
virus as it encountered a previously unexposed human population, both geographically and
temporally. A study of 63 isolates of SARSCoV, including animal and human strains was
performed by the Chinese SARS consortium to determine rates of mutation along the course
of the epidemic (Chinese, 2004). Complete sequencing of the isolates allowed detailed direct
and statistical analysis of adaptation in SARS-CoV, and it led to conclusions about the most
variable regions of the genome during the course of the epidemic. As expected, the S coding
region demonstrated the most mutations resulting in non-synonymous amino acid substitutions,
at a rate indicating significant positive selective pressure, and in a manner suggesting early
rapid change and late purifying adaptive changes (Chinese, 2004). Surprisingly, however, the
ORF1a polyprotein showed a rate of nonsynonymous substitutions similar to that in the S gene,
also tracking with early rapid change and late purifying mutations (Fig. 1). The ORF1b
polyprotein, in contrast, had little evidence of rapid change or positive selective pressure.
In addition, the data in that report suggests that the changes in the replicase may be even more
significant. Specifically, in the S coding region (1255aa) there were 22 nonsynonymous
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variations (NSV), of which 11 were nonconservative changes. In ORF1ab, there were 29 NSV,
of which 14 were nonconservative. When ORF1a (4369aa) is considered alone, there were 24
NSV with 11 nonconservative substitutions. Even more impressive, nsp 3 (1921aa) had 12
NSV, five of which were nonconservative, and the smaller nsp 4 (500aa) had nine NSV of
which four were nonconservative. This was in contrast to six NSV (four nonconservative) in
all of ORF1b (2703aa). These results support the conclusion that adaptations during the SARS
epidemic, with transmission from animals and among humans, was associated with substantial
changes in ORF1a, notably focused in nsps 3 and 4. These proteins are discussed in subsequent
sections, but the overall analysis suggests they may be important for survival and adaptation
in the host and thus may serve functions that are distinct from replication.
The adaptation of SARS-CoV observed in the Chinese Consortium studies was based on
introduction into humans, presumably from animals that functioned as replication
intermediates, transmitting a SARS-CoV precursor virus from a different stable animal
reservoir (Chinese, 2004). The rates and loci of changes are strong evidence for positive
selective pressure and adaptation for virulence and maintenance in human populations.
However, the analysis was not a prospective study of the capacity of SARS-CoV to adapt in a
new species. Such a study was performed by adaptation of SARS-CoV to virulence in mice.
Mice are known to support the replication of human isolates of SARS-CoV, but replication is
limited and without pathogenic correlates or mortality in young mice (Yount et al., 2005).
When the SARS-CoV Urbani strain was passaged 15 times in young mice, virus obtained at
passage 15 (MA-15) demonstrated rapid and reproducible lethality in the same mouse strain
(Roberts et al., 2007). Sequencing of the entire genome of the MA-15 virus identified six
mutations resulting in nonsynonymous substitutions. Surprisingly, of the six mutations, four
were in ORF1ab, with two in nsp 5, one in nsp 9 and one in nsp 12 (Fig. 1). The other two
mutations were identified in structural ORFs: one in ORF 2 (S), and one in ORF 5 (M). The
genetic recapitulation of the four-replicase mutations alone increased the virulence of SARS-
CoV in mice, and all six-substitution mutations restored the full virulence of the MA15 virus.
This is strong evidence that virulence-conferring mutations in ORF1ab are positively selected
during trans-species transmission of SARSCoV and SARS-like coronaviruses. Interestingly,
it suggests that even conservative nonsynonymous changes (e.g., Ala to Val) may be important
for virulence changes or replication in a new host.
2. Materials and methods
2.1. Viruses and cells
A recombinant form of severe acute respiratory syndrome coronavirus Urbani strain (SARS-
Urbani, or SARS-CoV in this report) was used as the wildtype control in all SARS-CoV
experiments. SARS-CoV Urbani reference sequence AY278741 was used for cloning studies.
African green monkey kidney (Vero-E6) cells were grown in MEM that contained 10% FBS
for SARS-CoV experiments.
2.2. Antibodies
The rabbit polyclonal antibodies described in the experiments in this report have been
previously described. They include α-nsp 1 (VU232), α-nsp 2 (VU239), and α-nsp 8 (VUGP14)
(Graham et al., 2005; Graham et al., 2006; Prentice et al., 2004b).
2.3. Construction of mutant SARS-CoV viruses
Deletions and amino acid substitutions at and near SARSCoV CS1 were achieved using site-
directed mutagenesis of SARS-CoV fragment A as before (Graham et al., 2005; Graham et al.,
2006). Primers used in mutagenesis are described in Table 1. For all primer sets, PCR was
performed from wildtype SARS-CoV fragment A, generating A-B and C-D amplicons. The
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resulting amplicons were then digested with Bbs I, ligated to form ABCD products, and inserted
into the fragment A background using native Nci I and Nco I restriction sites. Full-length
cDNAs were then assembled and mutant viruses recovered as detailed in Graham et al.
(2005), Graham et al. (2006) and Yount et al. (2003).
2.4. Protein immunoblots
SARS-CoV-infected cells were lysed in inactivation buffer containing 20 mM Tris-HCl pH
7.6, 150 mM NaCl, 0.5% DOC, 1% Nonidet P-40, and 0.1% SDS, and tested to confirm
inactivation (Darnell et al., 2004). Following centrifugation at 16,000 × g for 2 min to pellet
nuclei, supernatants were treated with 1 volume of 10 mM EDTA/0.9% SDS. Lysates were
then heated at twice at 90 °C for 30 min prior to use. Immunoblots to detect SARS-CoV proteins
were then performed as described in Prentice et al. (2004b). Images were processed using
Adobe Photoshop CS.
2.5. Indirect immunofluorescence detection of viral proteins
Vero-E6 cells were grown to 60% confluency on 12 mm glass coverslips and infected with
wildtype or mutant viruses. At 12 h p.i. and 20 h p.i., medium was aspirated from cells, and
cells were fixed and permeablized in -20 °C methanol overnight. Coverslips were transferred
to clean 24-well plates containing fresh methanol prior to removal from BSL-3 conditions.
Cells were then rehydrated in PBS for 20 min, then blocked in PBS containing 5% bovine
serum albumin (BSA). The following steps were performed in immunofluorescence assay
(IFA) wash solution (PBS containing 1% BSA and 0.05% Nonidet P-40) at room temperature.
Blocking solution was aspirated, and cells were incubated with primary antibodies at 1:200
dilution for 1 h. Cells were then washed in IFA wash solution three times for 10 min per wash.
Cells were then incubated in secondary antibodies (Goat α-rabbit-Alexa 488, 1:1000, and Goat
α-guinea pig-Alexa 546, 1:1000, Molecular Probes) for 45 min. Cells were washed again three
times for 10 min per wash, followed by a final wash in PBS, and then rinsed in distilled water.
Coverslips were mounted with Aquapolymount (Polysciences) and visualized by confocal
immunofluorescence microscopy on a Zeiss LSM 510 laser scanning confocal microscope at
488 and 543 nm with a 40× oil immersion lens. Images were processed and assembled using
Adobe Photoshop CS2 (9.0.2).
3. Results and discussion
3.1. Nonstructural proteins: adaptation and virulence
The above studies demonstrated by comparative analysis and selection in an animal host the
importance of ORF1ab proteins in host adaptation and virulence. Our work and that of others
has focused on defining protein domains within ORF1ab that are involved in replication, innate
immune response and virulence. A methodical approach has been taken towards determining
the requirement and functions of MHV nsps 1-16 in replication. To that end, numerous amino
acid residues, proteins, and protein domains have been identified that are dispensable for
replication but whose modification leads to attenuation in animals. These observations have
been applied by identifying the orthologous protein domains or amino acid residues of SARS-
CoV and using reverse genetic approaches to introduce the same modifications in SARS-CoV.
Together, the results demonstrate that proteins or protein domains of ORF1ab are critical for
efficient replication and virulence in SARS-CoV. In addition, it has become clear through these
studies that nsp order, expression level, and proteolytic processing may constitute distinct
virulence alleles.
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The first approximately 2700 aa of the ORF1ab polyprotein comprise the nsps 1-3 proteins
(Fig. 2). This region of ORF1ab is the most variable among coronaviruses. As a group 2b
coronavirus, SARS-CoV and the related SARS-like animal viruses have similar organization
and protein sizes as other group 2 coronaviruses, with the distinction that nsps 1-3 are processed
by a single PLP. Alignment of ORF1ab protein sequences of SARS-CoV with MHV or other
group 2a coronaviruses reveals significant identity and similarity in nsps 4-16, but very limited
identity or similarity of nsps 1-3. When the variability between nsp 3 isolates of the SARS
epidemic are compared, the results suggest that nsps 1-3 perform cell- and host-specific roles
in replication and/or virulence. Additionally, they have demonstrated high capacity for
adaptation to new environments and selective pressures. As a result, it is likely that these
proteins play dual roles in replication and pathogenesis that may vary widely between virus
groups.
3.2.1. Nsp 1—Two recent studies of SARS-CoV nsp 1 suggest that this protein of ORF1ab
may play specific roles in the interaction of the virus with the innate immune response.
Kamitami et al. observed that SARS-CoV replication in human 293 cells suppresses IFN-β
mRNA accumulation (Kamitani et al., 2006). Plasmid-based overexpression of nsp 1 resulted
in the inhibition of host gene expression by promoting degradation of host mRNA, and that
IFN-β mRNA accumulation was decreased without alteration of IRF-3 phosphorylation,
dimerization, or translocation. Further analysis showed that SARS-CoV nsp 1 suppressed
Sendai virus-induced IFN-β mRNA accumulation, and suppressed reporter mRNA
accumulation in cells. Degradation of preexisting mRNAs resulted in an overall inhibition of
cellular protein synthesis. The authors conclude that the degradation of host mRNA would
inhibit immune response genes such as IFN-β, and thus, that nsp 1 is likely a virulence factor.
Overexpression of nsp 1 in the lung epithelial cell line A549 increases the production of CCL5,
CXCL10 and CCL3 cytokines 30-200-fold compared with mock-transfected cells or cells
expressing nsp 5 (Law et al., 2006). Similar results were detected with CCL5 and CXCL10 in
HepG2 cells, suggesting that this was not a cell line-specific induction. NFκ-B expression
increased 10-14 h post-nsp 1 transfection, suggesting that cytokine induction occurred via an
NFκ-B-dependent pathway. In support of this hypothesis, expression of CCL5, CCL3 and
CXCL10 was reduced up to 60% in nsp 1-expressing cells in the presence of the IKK-β
inhibitor, sodium salicylate. In contrast, the cytokine induction was not detected upon
expression of nsp 1 of the group 2a coronaviruses MHV and OC43, nor with that of the group
1 coronavirus HCoV-229E. The authors conclude that expression of SARS-CoV nsp 1 plays
a role unique to the group 2-like coronaviruses in the regulation of chemokine expression.
These two recent reports suggest that SARS-CoV nsp 1 may serve multiple roles in
pathogenesis. Whether the protein is also required for virus replication remains to be
determined. Mutagenesis and deletion studies of MHV nsp 1 indicate that the protein can
tolerate substitution of clustered charged residues, as well as deletion of the carboxy-terminal
half of the protein, and still support recovery of viable virus with modest replication defects
(Fig. 2) (Brockway and Denison, 2005). However, the lack of effect of MHV nsp 1 in the
chemokine study, as well as the limited amino acid identity (<20%) between MHV and SARS-
CoV nsp 1 proteins, suggest that there may be more differences than similarities in these
proteins. The studies also raise the question of how nsp 1 can simultaneously induce host
mRNA degradation and specific gene expression. Confirmation of these results in 293, A549,
and HepG2 cells, as well as other naturally permissive and ACE 2-expressing cell lines, will
be crucial to reconcile these results. Finally, it will be critical to test these in vitro results during
virus infection in cells, specifically with genetically defined mutants of nsp 1, to determine if
mutations in nsp 1 alter the replication or pathogenesis of SARS-CoV in defined animal models.
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3.2.2. Nsps 2 and 3—The functions of nsp 2 are entirely unknown, while nsp 3 has multiple
conserved domains, including PLP activity, as well as putative functions in replication complex
formation and viral RNA synthesis and processing (Putics et al., 2005; Snijder et al., 2003).
However, recent studies with MHV and HCoV-229E suggest that all or portions of these
proteins may have functions in pathogenesis.
The nsps 2 and 3 proteins of MHV have been extensively studied using reverse genetic
mutation, deletion and modification of cleavage sites and viral proteinases. Nsps 2 and 3 of
MHV and SARS CoV are detected as mature processed proteins but also as nsps 2 and 3
intermediate precursors (Denison et al., 1992; Graham et al., 2005; Harcourt et al., 2004;
Schiller et al., 1998), suggesting that the nsps 2 and 3 precursor may be important in replication,
possibly serving distinct roles or regulating availability of mature nsps 2 and 3 proteins. The
requirement for processing of nsps 1-3 has been tested by engineered deletion of the cleavage
sites between nsps 1 and 2 and between nsps 2 and 3 (Fig. 2) (Denison et al., 2004; Graham
and Denison, 2006). In MHV, deletion of the nsp 1 | nsp 2 cleavage site resulted in recovery
of infectious virus with less than a 1-log10 reduction in peak virus titer in culture (Denison et
al., 2004). Deletion of the nsp 2 | nsp 3 cleavage site allowed recovery of virus that could not
process mature nsps 2 and 3 (Graham and Denison, 2006). Recovered viruses grew to wildtype
peak titer, but demonstrated delays in the initial increase in virus titer compared to wildtype
virus and other mutants that did not abolish cleavage of nsps 2 from 3. Nsp 1 | nsp 2 and nsp
2 | nsp 3 cleavage site deletions have been engineered into SARS-CoV and are being tested
for their effects on replication and pathogenesis in mice.
These results suggest that nsp 2 may regulate functions of nsps 1 and 3. Therefore, the entire
coding sequence of nsp 2 was deleted in both SARS-CoV and MHV, resulting in an in-frame
nsp 1 | nsp 3 junction containing a “new” chimeric nsp 1 | nsp 3 cleavage site. Surprisingly,
the nsp 2 deletion mutants of SARS-CoV and MHV were both viable, and were both able to
process the chimeric nsp 1 | nsp 3 cleavage site. The resulting mutant viruses had decreased
but not delayed growth. Together, these results indicate that the nsp 1 | nsp 2 cleavage site, the
nsp 2 | nsp 3 cleavage site, and in fact the entire nsp 2 protein, are dispensable for replication
in culture (Fig. 2). Thus, there is no absolute replication requirement for the mature nsps 1, 2,
or 3 proteins of MHV or SARS-CoV. More intriguing is the complete dispensability of nsp 2.
The ability to test a complete nsp 2 deletion with retained nsps 1 and 3 maturation will allow
the study of the role of nsp 2 in replication and pathogenesis in animal models.
As with nsp 2, in vitro and reverse genetic studies of specific domains of nsp 3 from MHV and
HCoV-229E have provided important insights into possible roles in replication and
pathogenesis. The Appr-1″-p domain of nsp 3 is proposed to have functions in viral RNA
synthesis (Snijder et al., 2003). Putics et al showed that the nsp 3 Appr-1″-p subdomain of both
SARS-CoV and HCoV-229E, when expressed alone in vitro, possess Appr-1″-p activity and
that the activity is abolished by substitutions at predicted catalytic residues (Putics et al.,
2005). However, when the inactivating mutation was engineered in recombinant HCoV-229E,
no change was seen in virus growth or RNA synthesis, demonstrating that the Appr-1″-p
activity is not essential for replication in culture, and raising questions about its role in the
infected host.
The PLP activities of nsp 3 may also serve roles in replication and pathogenesis that could
involve unique mechanisms or interactions with the host cell. SARS-CoV contains only a single
PLP, orthologous to MHV PLP2. The SARS PLP has been purified and shown to cleave
between nsp 1 | nsp 2, nsp 2 | nsp 3, and nsp 3 | nsp 4 and to recognize and cleave following a
P4-L(N/K)GGP1 sequence, with no clear requirement in the P1′ position. The L(X)GG motif
was noted to be similar to the recognition site of cellular deubiquitinating enzymes. Two groups
subsequently demonstrated that expressed and purified SARS PLP possesses deubiquitinating
Graham et al. Page 7













activity (Barretto et al., 2005; Lindner et al., 2005). The structure of the SARS-CoV core
catalytic PLP (aa1541-1855) was subsequently reported, demonstrating the structural
correlates of the biochemical results, and further confirming the recognition of the core P4-
LXGG-P1 (Ratia et al., 2006). The mechanism and role of deubiquitinating activity of SARS
PLP in replication remains to be determined, but the efficiency of deubiquitinating activity of
SARS-CoV PLP on artificial substrates suggests that it may be playing a role in modification
of host cell proteins, possibly in addition to recognition of the LXGG motif in viral
polyproteins. Finally, it has been shown that the SARS PLP can recognize and cleave peptides
containing the PLP cleavages sites of the group 2a viruses MHV and BCoV, but not the group
1 HCoV-229E, supporting the phylogenetic grouping of SARS-CoV as a group 2b coronavirus
and suggesting that studies of MHV may be most relevant to the further understanding of
SARS-CoV processing and PLP activities (Han et al., 2005).
In that regard, it has recently been demonstrated that MHV, which contains PLP1 and PLP2
proteinase activities in nsp 3, can be engineered with an inactivation of PLP1, resulting in
abolished cleavage at nsp 1 | nsp 2 and nsp 2 | nsp 3 (Fig. 2) (Graham and Denison, 2006) and
an uncleaved nsps 1-3 precursor. These PLP1 mutants were highly impaired on recovery, but
adapted over passage to regain near wildtype growth in culture without reversion of PLP1
inactivating mutations and without cleavage of nsps 1 from 2 and 3. Multiple putative adaptive
mutations have been identified, including mutations in nsp 3 in the Appr-1″-p and PLP2
domains, and these, both alone and together, have been confirmed to partially compensate
growth (Graham and Denison, unpublished results). Interestingly, monitoring the introduction
of mutations in the complete genome over 27 virus passages in culture identified new mutations
in ORF1a, ORF1b, S, and N. In addition, changes in the leader and transcriptional regulatory
sequences correlated with increased growth fitness. These observations suggest that the
ORF1ab proteins, notably nsp 3, may interact with multiple structural and nonstructural
proteins, as well as with regulatory sequences in viral RNA. Thus, it is likely that additional
functions in replication and pathogenesis will be defined for nsp 3.
3.2.3. Processing at the nsp 1 | nsp 2 cleavage site (CS1)—While SARS-CoV is
similar to group 2 coronaviruses such as MHV in many ways, it differs in the processing of
nsps 1 and 2. As has been discussed, SARS-CoV mediates processing of the nsp 1 | nsp 2 and
nsp 2 | nsp 3 cleavage sites (CS1 and CS2, respectively) with its single PLP, which is a PLP2
ortholog, rather than with a PLP1-like activity as is observed in MHV infection (Harcourt et
al., 2004; Snijder et al., 2003). However, SARS-CoV encodes an RG | V amino acid sequence
(aa 226-228), similar to that encoded at the MHV CS1, which is C-terminal from the GG | A
amino acid tripeptide (aa 179-181) that serves as the SARS-CoV CS1. To determine if the RG
| V sequence was recognized by the SARS-CoV PLP in the context of infection, three-amino
acid deletions of 226RG | V228 and 179GG | A181 were engineered into the SARS-CoV genome
(mutants A4 and A1, respectively) using reverse genetics (Fig. 3A). Additionally, a single-
amino acid substitution at the CS1 P1′ position was generated (Ala181Gly, mutant A2) which
was predicted to allow processing at CS1 to occur. All three mutants resulted in the recovery
of infectious virus. Upon examination of the nsps 1, 2, and 8 proteins in infected cells by
immunoblot, we confirmed that the 179GG | A181 deletion resulted in the loss of processing at
CS1, as evidenced by the lack of detection of mature 20 kDa nsp 1 and 70 kDa nsp 2 products
(Fig. 3B). Immunoblotting with both nsps 1 and 2 antibodies resulted in the detection of a
protein with a mobility of approximately 90 kDa, which corresponds to the predicted size of
an uncleaved nsp 1-2 precursor. Infection with the A2 and A4 mutants did not disrupt
processing at CS1, and there was no evidence of alternative processing at the 226RG | V228 site
in the A4 mutant. Interestingly, in the A1 mutant infection, additional proteins normally
detected in infected cells with nsp 2 antiserum with approximate mobilities of 42 and 100 kDa
also evidenced shifts that corresponded to increases of 10-20 kDa in size. These products,
which were not detected in wildtype or other mutant infections with nsp 1 antiserum, were
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detected in infections with the A1 mutant with nsp 1 antiserum, suggesting that these bands
represent nsp 2-containing intermediates or further processing products in the wildtype
infection and that these products are similarly processed in the A1 infection in spite of the lack
of processing at CS1. This processing strategy of nsp 2 is distinct from that observed with
MHV-A59 infection, but is reminiscent of that observed with MHV-JHM infection, in which
a 72 kDa nsp 2-containing species is further processed into a “mature” 65 kDa nsp 2 (Gao et
al., 1996; Schiller et al., 1998). The processing determinants of these possible alternative forms
of nsp 2 in SARS-CoV are not currently known.
3.2.4. Replication complex localization of nsps 1 and 2—It has been shown that, for
MHV, nsps 1 and 2 localize to replication complexes (Bost et al., 2000; Brockway et al.,
2004; Sims et al., 2000). While MHV nsp 2 localization to replication complexes is stable
throughout the course of infection, MHV nsp 1 localization is less stable. The interaction of
MHV nsp 1 with membrane populations has been shown to be largely peripheral in biochemical
studies, and at late times post-infection, nsp 1 exhibits characteristics similar to nsp 13 (hel)
and nucleocapsid (N) proteins, which have been shown to translocate to sites of virion assembly
(Brockway et al., 2004; Sims et al., 2000). To determine if SARS-CoV nsps 1 and 2 behave
similarly to MHV nsps 1 and 2, Vero cells were infected with wildtype, A1, or A4 mutants,
cells were fixed and permeablized, and nsps 1 and 2 proteins were visualized by indirect
immunofluorescence assay (Fig. 4). At 12 h post-infection (p.i.), wildtype nsps 1 and 2 both
displayed bright, punctate perinuclear localization, similar to that observed in MHV infection
(Fig. 4A). Both proteins colocalized with nsp 8, another replicase protein and a marker for
replication complexes. Similar patterns of localization were observed at 20 h p.i., which was
expected for nsp 2, but which was distinct from that shown for nsp 1 in MHV infection (data
not shown). Infection with the A1 mutant resulted in a similar pattern of localization for both
nsps 1 and 2 (Fig. 4B). Surprisingly, the A4 mutant, which displayed nsp 1 localization patterns
similar to what was seen in wildtype and A1 infection, evidenced an altered localization of nsp
2 in relation to the replication complex marker, nsp 8 (Fig. 4C). While nsp 2 localization was
still punctate, its pattern did not closely match that observed for nsp 8 (indicated by the
reduction in the proportionate number of yellow pixels in the merged image). This data suggests
that the deletion of the 226RGV228 in the A4 mutant may disrupt a domain of nsp 2 required
for proper replication complex interaction, though the formation of the replication complexes
is apparently not hindered, as evidenced by the localization of nsps 1 and 8. We have previously
shown for MHV that nsp 2 is not required for replication complex formation (Graham et al.,
2005), and while it is not surprising that such is the case for SARS-CoV, it is intriguing that
nsp 2 localization to punctate structures in the cytoplasm appears only altered rather than
completely abolished.
3.3. Nsp 4
The nsp 4 protein is also referred to as MP1 (membrane protein 1) for its multiple highly
hydrophobic stretches of amino acids predicted to span intracellular membranes (Fig. 5)
(Bonilla et al., 1994). Together, nsps 3, 4, and 6 are predicted to function to nucleate and anchor
viral replication complexes on double-membrane vesicles in the cytoplasm (Gosert et al.,
2002;Prentice et al., 2004a;van der Meer et al., 1999). Nsp 4 is the N-terminal-most ORF1ab
protein that shares greater than 50% identity and similarity with other coronavirus groups,
suggesting that nsp 4 protein function is important or essential for viral replication. Prior to
the establishment of a coronavirus reverse genetic system, analysis of nsp 4 began at the level
of identification of cleavage sites and proteases responsible for liberating the protein from the
polyprotein. It was discovered that SARS-CoV nsp 4 is cleaved first at its amino terminus by
the PLP (PLP2 for MHV) and at its carboxy terminus by 3CLPro (Harcourt et al.,
2004;Kanjanahaluethai et al., 2003;Prentice et al., 2004b). After nsp 4 has been cleaved from
the ORF1a polyprotein at its carboxy terminus, it can be detected as an intermediate precursor
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product that includes nsps 4-10 and has an approximate mass of 150 kDa (Kanjanahaluethai
et al., 2003). It is predicted that intermediate products may play important roles during either
replication or pathogenesis of coronaviruses. The second cleavage event of nsp 4 is mediated
by nsp 5, generating for MHV a protein with a predicted mass of 56 kDa but an apparent mass
of 44 kDa and for SARS-CoV a protein with a predicted mass of 55 kDa but an apparent mass
of 35 kDa (Kanjanahaluethai et al., 2003;Lu et al., 1996;Prentice et al., 2004b).
As described above, SARS-CoV nsp 4 showed evidence for substantial adaptation over the
course of the epidemic, with the rate of NSV and nonconservative substitutions equivalent to
that in S (Chinese, 2004). Based on these studies, deletions and alanine substitution of clustered
charged residues were engineered in MHV nsp 4, targeting residues that are identical in SARS-
CoV nsp 4 (Fig. 5). Using this approach, nsp 4 mutant viruses have been recovered that have
multiple plaque and growth phenotypes, ranging from small plaque size and decreased growth,
to wild type plaque size and growth (Sparks et al., unpublished results). Most surprising, nsp
4 tolerated deletion of the carboxy-terminal 100 aa, or 20% of the coding sequence, and the
mutant virus with this deletion had no detectable growth defect compared to wild type virus.
The nsp 4 carboxy-terminal deletion has been cloned for introduction into the SARS-CoV
genome. If infectious virus is recovered, this will be a strong candidate for evaluation in
replication and pathogenesis in animal models. These results suggest that nsp 4 has dispensable
regions for replication, or that it possibly has domains that are dedicated to other functions not
directly related to virus replication.
3.4. Nsp 14
Nsp 14 is an ORF1b protein that is downstream from nsp 12 (RdRp) and nsp 13 (helicase/
NTPase/RNA 5′-triphosphatase) and upstream from nsp 15 (nidovirus uridylate-specific
endoribonuclease) and nsp 16 (putative 2′-O-RNA methyltransferase) (Bhardwaj et al., 2004;
Ivanov et al., 2004a,b; Snijder et al., 2003; Thiel et al., 2003). The expression of nsp 14, which
is cleaved from nsps 13 and 15 by nsp 5, is proposed to involve an intermediate precursor of
nsps 12-16 (Denison et al., 1991). Nsp 14 likely functions coordinately with nsps 15 and 16 in
processing and modification of viral or cellular RNAs. Nsp 14 was first predicted, and more
recently demonstrated in biochemical studies using bacterially expressed and purified full-
length nsp 14, to possess 3′-5′ exonuclease activity on RNA but not on DNA substrates
(Minskaia et al., 2006; Snijder et al., 2003). All coronavirus nsp 14 sequences have conserved
putative active site residues that allow assignment of nsp 14 to the DE-D-D superfamily of
exonucleases, named after the four invariant acidic residues of the active site (Fig. 6). Alanine
substitution of the conserved active site residues diminished or eliminated exonuclease activity
of purified SARS-CoV nsp 14 in vitro. When alanine substitution of the active site DE or other
residues was engineered in the context of the full-length infectious clone of HCoV-229E,
genomic and subgenomic viral RNAs were detected in transfected cells but no virus was
recovered, suggesting that nsp 14 was essential for virus replication (Minskaia et al., 2006).
The initial studies of MHV nsp 14 resulted from the observation that the original recombinant
clone of MHV-A59 was phenotypically wildtype in all aspects of growth in cell culture, but
surprisingly had no measurable LD50 and appeared completely attenuated in mice (Sperry et
al., 2005). This unexpected result led to comprehensive sequencing of the cloned cDNA
fragments used to assemble the full-length MHV cDNA, and analysis identified two single-
nucleotide mutations, each resulting in nonconservative amino acid substitutions: one at Y414
in nsp 14 and one in an accessory protein unique to MHV, the ORF2a protein. Sequencing of
recombinant virus confirmed the presence of the Y414H substitution. When the wildtype Y414
and mutant Y414H cDNAs were compared, both displayed wild-type growth in cell culture.
However, the Y414 virus was virulent in mice, whereas the Y414H mutant was completely
attenuated, even in the absence of the mutation in the 2a protein (Sperry et al., 2005). This was
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the first demonstration in coronavirus ORF1ab of a mutation that does not impact replication
in culture but attenuates virulence in an animal host, and thus, this study provides strong
evidence for a role of nsp 14 distinct from or in addition to any function in replication.
The above results led to a reconsideration of the domain organization of nsp 14 and possible
functions in replication and pathogenesis. The exoribonuclease (ExoN) motifs of nsp 14 are
located in the amino-terminal half of the 521-aa MHV nsp 14 protein (SARS-CoV nsp 14 is
527 aa). In contrast, the Y414 residue is in the carboxy-terminal half of the protein, which has
no predicted role in ExoN activity, no known function, and no significant homology to other
proteins. To address the role of nsp 14 in MHV replication, a variety of mutations and deletions,
including deletion of the proteinase cleavage sites at either terminus of nsp14, substitution of
ExoN catalytic residues, substitution of Y414 with other amino acids, and deletion of Y414
(Fig. 6)(Eckerle et al., 2006) was engineered in the nsp14 coding sequence and tested for virus
viability and growth in cell culture. When P1-Gln of either the nsp 13 | nsp 14 or the nsp 14 |
nsp 15 cleavage site was deleted, mutant viruses were recovered, although the growth of the
nsp 13 | nsp 14 cleavage site mutant is markedly delayed. Most nsp 14 Y414 substitution
mutants were recovered and demonstrated near or equivalent to wildtype growth in culture.
When the Y414H substitution was recapitulated at the conserved SARS-CoV Y420 residue,
viable virus was recovered and is currently being analyzed for its effect on SARS-CoV
replication and virulence in animal models.
The results of the current and previous studies on nsp 14 raise important questions concerning
the role of nsp 14 in RNA processing, virus replication, and pathogenesis. Are the natural
substrates of ExoN activity viral or cellular RNAs? Does the carboxy-terminal half of nsp 14
modulate ExoN activity, and if so, is Y414 involved? Does nsp 14 serve other functions in
virus replication? Does the protein have a unique role in subgenomic RNA synthesis? Is ExoN
activity required for coronavirus replication and virulence in animals? What is the mechanism
of attenuation caused by the Y414H substitution in MHV nsp 14? To answer these questions,
it will be essential to develop biochemical assays with nsp 14 from other coronaviruses and to
determine the effects of additional nsp 14 mutations in both MHV and SARS-CoV on virus
replication, viral RNA synthesis, and virulence.
3.5. Other nsps: structures and mutants lead the way
Most coronaviruses express and process 15 or 16 confirmed or predicted mature proteins from
their OR1ab polyproteins, in addition to at least three intermediate precursors that may have
additional functions. It is beyond the scope of this review to detail the putative functions, cell
biology, and mutagenesis of all of these proteins. However, in relation to viral pathogenesis,
important strides have been made in providing a basis for studies of these proteins in the
pathogenesis of SARS-CoV and other coronaviruses. First, the structures have been reported
for all or parts of nsp 3, 5 (3CLpro or Mpro), 7-10, and 15 (Bhardwaj et al., 2006; Chou et al.,
2004; Egloff et al., 2004; Joseph et al., 2006; Lee et al., 2005; Ratia et al., 2006; Ricagno et
al., 2006; Saikatendu et al., 2005; Su et al., 2006; Sutton et al., 2004; Tan et al., 2005; Zhai et
al., 2005). These results show remarkable multimeric protein interactions, raising important
questions about the expression and interactions of the proteins as they are processed from the
ORF1ab polyprotein. For example, how does the proposed hexameric structure of nsp 15 (Xu
et al., 2006) interact with the proposed dodecameric structure of nsp 10 (Joseph et al., 2006;
Su et al., 2006)?
Second, a recent careful analysis of long established temperature-sensitive MHV mutants has
defined new targets for the rich interface between forward and reverse genetic analyses of
SARS-CoV and other coronaviruses in replication and pathogenesis. Sawicki et al. performed
sequencing of ORF1 from a large panel of available temperature-sensitive (ts) mutants with
different conditional defects, including lethality, that were generated in several labs and were
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the basis for establishing complementation groups (Sawicki et al., 2005). The report identified
single point mutations resulting in nonsynonymous substitutions in nsps 4, 5, 10, 12, 14 and
16. The overall results suggest that the ORF1b nsp 12, 14 and 16 proteins define distinct
cistrons, while the mutants in ORF1a proteins nsps 4, 5, and 10 form a single complementation
group, a conclusion that is in line with the proposed processing schemes and location in the
ORF1ab coding sequence. Additionally, the study provides some valuable insights. Notably,
of the eight reported ts mutations in MHV, seven of the affected amino acid residues are
identical in SARS-CoV, and the eighth was Asn in MHV nsp 4 and Asp in SARS-CoV nsp 4.
While the mutants were analyzed for their conditional growth defects and possible roles in
RNA synthesis, it should be possible to reproduce the amino acid changes using multiple
nucleotide mutations, thus stabilizing the amino acid substitution. This approach may allow
selection of phenotypic revertants that will identify protein interactions and new functions in
both replication and pathogenesis. In addition, it will allow the changes to be introduced in
SARS-CoV to determine if the ts phenotype can be recreated in that background, with the
possibility of rapidly establishing a panel of SARS-CoV conditional growth mutants.
4. Conclusions
The exciting advances in the evolution, genetics, replication and pathogenesis of SARS-CoV
and other coronaviruses has raised many important questions concerning the role of ORF1ab
proteins in all of the stages that comprise the pathogenic pathway of SARS-CoV:
1. Do the changes across the replicase from bats to civets to humans represent important
host range or pathogenic determinants? Do the patterns of change reflect host-specific
adaptations in replication or virulence?
2. Are SARS-CoV mutants within ORF1ab proteins or processing networks from other
coronaviruses viable, and if so, are they altered in replication and virulence in animal
models?
3. Are replicase proteins specifically altering host gene expression, and specifically
pathways that alter immune response?
4. Do mutations and deletions in SARS-CoV nsp 1 alter inter-feron and cytokine
responses in infected cells or animals?
5. Are replicase proteins altering host gene expression or immune response in ways that
are virus- and/or host-specific?
6. Can avirulent SARS-CoV replicase mutants provide protective immunity from
wildtype SARS-CoV infection?
Addressing these questions will help us further our understanding of the interplay between
SARS-CoV replication and pathogenesis in the host.
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SARS-CoV genome organization, ORF1ab protein expression and amino acid substitutions.
(A) Genome and ORF1ab organization. The SARS-CoV genome is a positive-strand RNA
molecule ~29 kb in length. The organization of ORF1a and 1b is shown, with the position of
the -1 ribosomal frameshift indicated (RF). The remaining genes are indicated by vertical lines,
and notation for genes encoding spike (S), envelope (E), membrane (M) and nucleocapid (N).
The polyprotein resulting from translation of ORF1ab is shown (pp1a), with vertical lines and
nonstructural (nsp) numbers 1-16. Nsp 11 is a theoretical 13aa peptide (not shown). The papain-
like proteinase (PLP) of nsp 3 and 3C-like proteinase (3CLpro) of nsp 5 are grey boxes. The
location of the PLP1 enzyme present in MHV but not SCoV is indicated by grey box with
hatched border. Activities are indicated for nsp 12 (RNA-dependent RNA polymerase—
RdRp), nsp 13 (helicase—Hel), nsp 14 (3'-5' exoribonuclease—ExoN), nsp 15
(endoribonuclease—NendoU), and nsp 16 (2'-O-methyltransferase—O-MT). Solid and dashed
lines below the ORF1ab proteins indicate location of conservative and non-conservative
nonsynonymous adaptive substitutions, respectively. Arrows indicate location of mutations in
mouse adapted SARS-CoV. (B) Location of evolutionary adaptive and mouse adaptive
mutations. Nsp numbers are indicated, with table showing adaptive mutations, non-
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conservative changes (bold) and mouse adaptive mutations (MA) by residue number and
substitution.
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Organization of and viable mutants generated within coronavirus nsps 1-3. The organization
and predicted and confirmed domains of MHV and SARS-CoV nsps 1-3 are shown. Gray boxes
indicate discrete domains within nsp 3. The nsps 1-2 and 2-3 cleavage sites (CS1 and CS2,
respectively) are delineated by amino acid number. Catalytic Cys, His, and Asp residues for
each PLP are indicated by amino acid number. Deletion of cleavage sites and portions of or
whole proteins, and the inactivation of the MHV PLP1 catalytic site are indicated by delta
(△) signs, and the deleted amino acid residues are indicated. Domains within nsp 3 are as
follows—Ac: acidic domain; PLP1: papain-like proteinase 1; X: X domain (ADP ribose 1 ”-
phosphatase activity); PLP2: papain-like proteinase 2 (SARS PLP is orthologous to MHV
PLP2); ZnR: zinc ribbon domains within PLPs; DUB: Core motif for deubiquitinating activity;
Y: Y domain.
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Mutation of SARS-CoV CS1 and identification of nsps 1 and 2 precursor. (A) The schematic
shows locations of experimentally identified CS1 and MHV-like RG | V recognition sequence.
Mutants generated are identified beneath the schematic. Numbering refers to amino acid
sequence from the beginning of ORF1a. (B) Immunoblot of mock- and SARS-CoV-infected
lysates. Mutant designations are as in A. Vero cells were infected with indicated viruses,
harvested at 12 h p.i., and resolved by SDS-PAGE. Antibodies used are against nsp 1 (top),
nsp 2 (middle), and nsp 8 (bottom). Molecular weights are indicated to the left of the images.
Protein bands are indicated with arrows to the right of images. Putative precursors and
maturation products are indicated with circles.
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Immunofluorescence of SARS-CoV-infected cells. Vero cells on glass coverslips were infected
with wildtype (wt, A), A1 (B), or A4 (C) viruses. Mutant designations are as outlined in Fig.
3. Cells were fixed and permeablized with methanol at 12 h p.i. Fixed coverslips were then
stained for nsps 1 or 2 along with nsp 8 as a marker for replication complexes. Images were
obtained using a Zeiss LSM 510 confocal microscope and were processed using Adobe
Photoshop CS2 (9.0.2).
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Schematic of MHV and SARS-CoV nsp 4 motifs, deletions and mutations. The schematic
shows the aa organization of MHV (496aa) and SARS-CoV (500aa) nsp 4. Black boxes show
the location and sequences of predicted transmembrane domains 1-4 (TM-1-4) with the
predicted aa boundaries for MHV (M) and SARS-CoV (S). TM4 has been deleted in viable
MHV mutants. The hatched box shows the region of the MHV nsp 4 carboxy terminus that
has been deleted in a viable mutant, and the corresponding SARS-CoV aa sequence, Note that
the nsps 4 and 5 cleavage site was not deleted. Black circles show the location of clustered
charge-to-alanine mutants viable in MHV and conserved in SARS-CoV. The white circle
shows the location of the published MHV Alb ts6 mutation (N258T) and the corresponding
SARS-CoV D259 residue.
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Motifs and substitution sites in nsp 14. The organization of nsp 14 is shown. Exonuclease
motifs I through III (black boxes) and a putative zinc finger motif (hatched box) are shown.
Location of reported MHV mutations conferring a ts phenotype are shown by residue number
and substitution, along with the conserved SARS-CoV residues below. The virulence-
attenuating Y414H mutant of MHV is shown, with conserved SARS-CoV Y420. A partial
sequence alignment of coronavirus nsp 14 sequences from MHV-A59, SARS-CoV, and human
coronavirus 229E with that of S. cerevisiae PAN2, a poly(A)-specific exoribonuclease, is
shown at the bottom. Completely conserved exonuclease active site and zinc-coordinating
residues are shown in bold, with DE-D-D aa numbers shown for SARS-CoV.
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Table 1
Primers used in mutagenesis of SARS-CoV CS1
Primer name Sequence Sense Purpose
SCS1 A 5′-CCGGGTGTGACCGAAAGGTAAGATGGAGAGCCT-3′ + Common left primer (A +B)
SCS1 D 5′-CCATGGCGTCGACAAGACGTAATGACTGTTCAGA-3′ - Common right primer (C+ D)
A1 B 5′-GAAGACGCCAATGTCACTCGCTATGTCGACAAC-3′ + Mutagenesis of CS1 P2-P1′
A1 C 5′-GAAGACGGATTGAGCTCACGAGTGAGTTCACG-3′ - Mutagenesis of CS1 P2-P1′
A4 B 5′-GAAGACGGGAAGTACTGCTGCCGTGACCATGA-3′ + Mutagenesis of MHV-like RGV
A4 C 5′-GAAGACGGCTTCGACTCGATGTAATCAAGTTGTT-3′ - Mutagenesis of MHV-like RGV
A2 B 5′-GAAGACCCGTGTCACTCGCTATGTCGACAACAAT-3′ + Mutagenesis of CS1 P1′
A2 C 5′-GAAGACCCACACCACCTCCATTGAGCTCACGAG-3′ - Mutagenesis of CS1 P1′
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